je.st
news
Tag: vaccine
ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product
2013-10-23 13:30:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that ZOSTAVAX (Zoster Vaccine Live), the company's vaccine to help prevent shingles, received the Prix Galien USA 2013 Award for Best Biotechnology Product. Language: English Contact: Media:MerckCaroline Lappetito, (267) 305-7639 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Vaccine company chooses Guilford for $7.6M facility, 31 jobs
2013-10-16 04:42:30| Air Courier - Topix.net
FFF Enterprises, a flu vaccine distributor, is planning to invest $7.6 million into a new facility in the Triad Business Park.
Tags: company
jobs
facility
chooses
USDA Approves First Combination MLV Vaccine To Provide Targeted Protection Against BVD 1b
2013-10-09 16:33:29| Beef
The U.S. Department of Agriculture (USDA) has issued the Veterinary Biological License for Viralign 6®, the first combination modified-live virus (MLV) vaccine to provide targeted protection against bovine viral diarrhea (BVD) virus 1b — the most predominant BVD virus strain in the United States.1 Marketed by Elanco, Viralign 6 also provides protection against BVD viral strains 1a and 2, bovine respiratory syncytial virus (BRSV), infectious bovine rhinotracheitis (IBR) virus and parainfluenza3 (PI3) virus. read more
Tags: provide
protection
combination
targeted
Experts in Africa cautious on potential malaria vaccine
2013-10-09 01:23:50| Biotech - Topix.net
DURBAN, South Africa: Expe rts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution Tuesday at hopes that the first vaccine against the killer disease may soon reach the market.
Tags: potential
africa
experts
vaccine
Malaria Vaccine 'Could Be Widespread By 2015'
2013-10-08 03:15:58| Biotech - Topix.net
The world's first malaria vaccine could be in widespread use within two years following "significant" results from an ongoing clinical trial.
Tags: widespread
vaccine
malaria
Sites : [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] next »